ID

31986

Beschrijving

A Study to Evaluate the Efficacy of Tacrolimus in Rheumatoid Arthritis Patients Shown Unsuccessful Response to Methotrexate; ODM derived from: https://clinicaltrials.gov/show/NCT01224418

Link

https://clinicaltrials.gov/show/NCT01224418

Trefwoorden

Versies (1)
  1. 10-10-18 10-10-18 -
Houder van rechten

See clinicaltrials.gov

Geüploaded op

10 oktober 2018

DOI

Voor een aanvraag inloggen.

Licentie

Creative Commons BY 4.0
Model Commentaren :

Hier kunt u commentaar leveren op het model. U kunt de tekstballonnen bij de itemgroepen en items gebruiken om er specifiek commentaar op te geven.

Terug naar het model Commentaren
Itemgroep Commentaren voor :

Item Commentaren voor :

U moet ingelogd zijn om formulieren te downloaden. AUB inloggen of schrijf u gratis in.

Eligibility Rheumatoid Arthritis NCT01224418

Engels

Eligibility Rheumatoid Arthritis NCT01224418

1 Formulieren  
Inclusion Criteria
Beschrijving

Inclusion Criteria

Alias
UMLS CUI
C1512693
patients with more than 6 months history of rheumatoid arthritis according to acr criteria
Beschrijving

Rheumatoid Arthritis Disease length

Datatype

boolean

Alias
UMLS CUI [1,1]
C0003873
UMLS CUI [1,2]
C0872146
patients who have been treated unsuccessfully to more than single dmards including methotrexate at the discretion of investigator
Beschrijving

DMARDs Quantity Treatment unsuccessful | Methotrexate Treatment unsuccessful

Datatype

boolean

Alias
UMLS CUI [1,1]
C0242708
UMLS CUI [1,2]
C1265611
UMLS CUI [1,3]
C0438286
UMLS CUI [2,1]
C0025677
UMLS CUI [2,2]
C0438286
esr ≥ 30 mm/h or crp ≥ 1.0 mg/dl (esr: erythrocyte sedimentation rate, crp: c-reactive protein)
Beschrijving

Erythrocyte sedimentation rate measurement | C-reactive protein measurement

Datatype

boolean

Alias
UMLS CUI [1]
C1176468
UMLS CUI [2]
C0201657
patients are required to have at least 3 of 66 joints assessed as swollen
Beschrijving

Swollen joint count

Datatype

boolean

Alias
UMLS CUI [1]
C0451521
patients are required to have at least 6 of 68 joints assessed as painful with pressure
Beschrijving

Painful joints With Pressure Count

Datatype

boolean

Alias
UMLS CUI [1,1]
C0003862
UMLS CUI [1,2]
C0332287
UMLS CUI [1,3]
C1306345
UMLS CUI [1,4]
C0750480
Exclusion Criteria
Beschrijving

Exclusion Criteria

Alias
UMLS CUI
C0680251
pregnant or breast-feeding patients. patients who plan to bear children or breast-feed during the study and within 6 month after completion of study
Beschrijving

Pregnancy | Breast Feeding | Pregnancy, Planned | Breast Feeding Planned

Datatype

boolean

Alias
UMLS CUI [1]
C0032961
UMLS CUI [2]
C0006147
UMLS CUI [3]
C0032992
UMLS CUI [4,1]
C0006147
UMLS CUI [4,2]
C1301732
previous experience of tacrolimus (ointment excluded)
Beschrijving

Tacrolimus | Ointment Excluded

Datatype

boolean

Alias
UMLS CUI [1]
C0085149
UMLS CUI [2,1]
C0028912
UMLS CUI [2,2]
C0332196
renal impairment or serum creatinine > 1.4 mg/dl
Beschrijving

Renal Insufficiency | Creatinine measurement, serum

Datatype

boolean

Alias
UMLS CUI [1]
C1565489
UMLS CUI [2]
C0201976
liver function failure as follows: viral hepatitis, non-viral hepatitis, cirrhosis, sgot/sgpt > 2x upper limit normal
Beschrijving

Liver Failure | Viral hepatitis | Non-viral hepatitis | Liver Cirrhosis | Aspartate aminotransferase increased | Alanine aminotransferase increased

Datatype

boolean

Alias
UMLS CUI [1]
C0085605
UMLS CUI [2]
C0042721
UMLS CUI [3]
C4268643
UMLS CUI [4]
C0023890
UMLS CUI [5]
C0151904
UMLS CUI [6]
C0151905
patients with history of pancreatitis, glucose intolerance or complication or who indicates any of the following criteria:blood glucose level >110mg/dl before the meal and >200mg/dl after the meal hba1c > 6.4%
Beschrijving

Pancreatitis | Impaired glucose tolerance | Glucose Complication | Blood glucose measurement ante cibus | Blood glucose measurement Postprandial | Hemoglobin A1c measurement

Datatype

boolean

Alias
UMLS CUI [1]
C0030305
UMLS CUI [2]
C0271650
UMLS CUI [3,1]
C0017725
UMLS CUI [3,2]
C0009566
UMLS CUI [4,1]
C0392201
UMLS CUI [4,2]
C1550738
UMLS CUI [5,1]
C0392201
UMLS CUI [5,2]
C0376674
UMLS CUI [6]
C0474680
cardiac disease(ischemic heart disease, treatment-requiring arrhythmia, heart failure)or complications
Beschrijving

Heart Disease | Myocardial Ischemia | Cardiac Arrhythmia Treatment required for | Heart failure | Cardiac complication

Datatype

boolean

Alias
UMLS CUI [1]
C0018799
UMLS CUI [2]
C0151744
UMLS CUI [3,1]
C0003811
UMLS CUI [3,2]
C0332121
UMLS CUI [4]
C0018801
UMLS CUI [5]
C0161816
other investigational drug within last 30 days
Beschrijving

Investigational New Drugs

Datatype

boolean

Alias
UMLS CUI [1]
C0013230
patients who have been treated with infliximab, adalimumab, or leflunomide within 8 weeks of start of the study
Beschrijving

infliximab | adalimumab | leflunomide

Datatype

boolean

Alias
UMLS CUI [1]
C0666743
UMLS CUI [2]
C1122087
UMLS CUI [3]
C0063041
Terug naar het begin van de pagina

Similar models

Eligibility Rheumatoid Arthritis NCT01224418

1 Formulieren
Name
Type
Description | Question | Decode (Coded Value)
Datatype
Alias
Item Group
C1512693 (UMLS CUI)
Rheumatoid Arthritis Disease length
Item
patients with more than 6 months history of rheumatoid arthritis according to acr criteria
boolean
C0003873 (UMLS CUI [1,1])
C0872146 (UMLS CUI [1,2])
DMARDs Quantity Treatment unsuccessful | Methotrexate Treatment unsuccessful
Item
patients who have been treated unsuccessfully to more than single dmards including methotrexate at the discretion of investigator
boolean
C0242708 (UMLS CUI [1,1])
C1265611 (UMLS CUI [1,2])
C0438286 (UMLS CUI [1,3])
C0025677 (UMLS CUI [2,1])
C0438286 (UMLS CUI [2,2])
Erythrocyte sedimentation rate measurement | C-reactive protein measurement
Item
esr ≥ 30 mm/h or crp ≥ 1.0 mg/dl (esr: erythrocyte sedimentation rate, crp: c-reactive protein)
boolean
C1176468 (UMLS CUI [1])
C0201657 (UMLS CUI [2])
Swollen joint count
Item
patients are required to have at least 3 of 66 joints assessed as swollen
boolean
C0451521 (UMLS CUI [1])
Painful joints With Pressure Count
Item
patients are required to have at least 6 of 68 joints assessed as painful with pressure
boolean
C0003862 (UMLS CUI [1,1])
C0332287 (UMLS CUI [1,2])
C1306345 (UMLS CUI [1,3])
C0750480 (UMLS CUI [1,4])
Item Group
C0680251 (UMLS CUI)
Pregnancy | Breast Feeding | Pregnancy, Planned | Breast Feeding Planned
Item
pregnant or breast-feeding patients. patients who plan to bear children or breast-feed during the study and within 6 month after completion of study
boolean
C0032961 (UMLS CUI [1])
C0006147 (UMLS CUI [2])
C0032992 (UMLS CUI [3])
C0006147 (UMLS CUI [4,1])
C1301732 (UMLS CUI [4,2])
Tacrolimus | Ointment Excluded
Item
previous experience of tacrolimus (ointment excluded)
boolean
C0085149 (UMLS CUI [1])
C0028912 (UMLS CUI [2,1])
C0332196 (UMLS CUI [2,2])
Renal Insufficiency | Creatinine measurement, serum
Item
renal impairment or serum creatinine > 1.4 mg/dl
boolean
C1565489 (UMLS CUI [1])
C0201976 (UMLS CUI [2])
Liver Failure | Viral hepatitis | Non-viral hepatitis | Liver Cirrhosis | Aspartate aminotransferase increased | Alanine aminotransferase increased
Item
liver function failure as follows: viral hepatitis, non-viral hepatitis, cirrhosis, sgot/sgpt > 2x upper limit normal
boolean
C0085605 (UMLS CUI [1])
C0042721 (UMLS CUI [2])
C4268643 (UMLS CUI [3])
C0023890 (UMLS CUI [4])
C0151904 (UMLS CUI [5])
C0151905 (UMLS CUI [6])
Pancreatitis | Impaired glucose tolerance | Glucose Complication | Blood glucose measurement ante cibus | Blood glucose measurement Postprandial | Hemoglobin A1c measurement
Item
patients with history of pancreatitis, glucose intolerance or complication or who indicates any of the following criteria:blood glucose level >110mg/dl before the meal and >200mg/dl after the meal hba1c > 6.4%
boolean
C0030305 (UMLS CUI [1])
C0271650 (UMLS CUI [2])
C0017725 (UMLS CUI [3,1])
C0009566 (UMLS CUI [3,2])
C0392201 (UMLS CUI [4,1])
C1550738 (UMLS CUI [4,2])
C0392201 (UMLS CUI [5,1])
C0376674 (UMLS CUI [5,2])
C0474680 (UMLS CUI [6])
Heart Disease | Myocardial Ischemia | Cardiac Arrhythmia Treatment required for | Heart failure | Cardiac complication
Item
cardiac disease(ischemic heart disease, treatment-requiring arrhythmia, heart failure)or complications
boolean
C0018799 (UMLS CUI [1])
C0151744 (UMLS CUI [2])
C0003811 (UMLS CUI [3,1])
C0332121 (UMLS CUI [3,2])
C0018801 (UMLS CUI [4])
C0161816 (UMLS CUI [5])
Investigational New Drugs
Item
other investigational drug within last 30 days
boolean
C0013230 (UMLS CUI [1])
infliximab | adalimumab | leflunomide
Item
patients who have been treated with infliximab, adalimumab, or leflunomide within 8 weeks of start of the study
boolean
C0666743 (UMLS CUI [1])
C1122087 (UMLS CUI [2])
C0063041 (UMLS CUI [3])
Terug naar het begin van de pagina 

Contact

Gebruik dit formulier voor feedback, vragen en verbeteringsvoorstellen.

Velden gemarkeerd met een * zijn verplicht.

Help

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial